Product Description
The global multi-parameter vital signs monitoring market was valued at $4.4 billion in 2024. This is expected to increase over the forecast period at a CAGR of 3.7% to reach over $5.7 billion.
The full report suite on the global market for multi-parameter vital signs monitoring includes low-acuity vital signs monitors, mid-acuity vital signs monitors, high-acuity vital signs monitors and central station devices.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL MULTI-PARAMETER VITAL SIGNS MONITORING MARKET TRENDS
The use of monitoring is expanding as part of increasing safety measures and initiatives to prevent unnecessary deaths. Hospitals are increasing their monitoring capabilities, particularly in low-acuity areas. New technologies will provide monitoring solutions, in many cases continuous, but will not require a tremendous increase in workflow or staffing. This is expected to be particularly prominent within developing countries and regions that are still in a period of rapid expansion in terms of access to healthcare.
GLOBAL MULTI-PARAMETER VITAL SIGNS MARKET SHARE INSIGHTS
- Philips Healthcare was the leading competitor in the global multi-parameter vital signs monitoring market in 2024. With one of the most extensive product lines of any company in the multi-parameter vital signs monitoring market, Philips Healthcare sold products in each of the four segments of this market. The company was the market leader in the central station monitoring market, as well as in mid- and high-acuity monitoring. Philips is also a notable competitor in the low-acuity market.
- GE Healthcare was the second-leading competitor in the multi-parameter vital signs monitoring market in 2024. GE, being an American company, has most of its multi-parameter vital signs monitoring business concentrated in North America, where it held a relatively close position to Philips. The company continues to generate notable revenue in Western Europe and the rest of the world but competes much more closely with international competitors like Mindray and Nihon Kohden. Part of this increased level of competition stems from GE Healthcare’s emphasis on high-acuity monitors, which are relatively less popular globally compared with in North America.
- Mindray Medical ranked as the third-leading competitor in the global multi-parameter vital signs monitor market in 2024. Its strength can be attributed to its affordable prices and quality products, which translated noticeably in the company’s presence in the low-acuity and mid-acuity segments. This type of product portfolio also benefits Mindray on the regional level, where it generates most of its revenue from Western Europe and the rest of the world. The company continues to be notable in North America, but is a distant third to Philips and GE. In contrast, the company competes closely with GE in the remaining regions, often holding a slight lead.
GLOBAL MULTI-PARAMETER VITAL SIGNS MONITORING MARKET SEGMENTATION SUMMARY
- High-Acuity Monitor Market
- Mid-Acuity Monitor Market
- Low-Acuity Monitor Market – Further Segmented Into:
- Device Type: Bedside Monitor, and Spot-Check Monitors.
- Central Station Monitor Market
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
